NOVITIUM PHARMA Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVITIUM PHARMA, and what generic alternatives to NOVITIUM PHARMA drugs are available?
NOVITIUM PHARMA has seventy-three approved drugs.
There is one US patent protecting NOVITIUM PHARMA drugs.
Summary for NOVITIUM PHARMA
| US Patents: | 1 |
| Tradenames: | 66 |
| Ingredients: | 65 |
| NDAs: | 73 |
Drugs and US Patents for NOVITIUM PHARMA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novitium Pharma | PYRIDOSTIGMINE BROMIDE | pyridostigmine bromide | SYRUP;ORAL | 211694-001 | Mar 8, 2019 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novitium Pharma | ESTRADIOL | estradiol | TABLET;ORAL | 217334-002 | Sep 6, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novitium Pharma | ESTRADIOL | estradiol | GEL;TRANSDERMAL | 217610-003 | Aug 24, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novitium Pharma | BETAINE | betaine | FOR SOLUTION;ORAL | 214864-001 | Nov 23, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novitium Pharma | DIGOXIN | digoxin | TABLET;ORAL | 215307-002 | Nov 22, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novitium Pharma | INDOMETHACIN | indomethacin | SUSPENSION;ORAL | 217883-001 | Jan 12, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
